Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1987 Mar;71(3):192–196. doi: 10.1136/bjo.71.3.192

Use of contrast sensitivity measurement in the detection of subclinical ethambutol toxic optic neuropathy.

J F Salmon, T R Carmichael, N H Welsh
PMCID: PMC1041117  PMID: 3828274

Abstract

Contrast sensitivity was measured by means of Arden grating plates in 100 patients on medication for pulmonary tuberculosis. The scores were abnormal in 38.2% of the patients whose therapy included ethambutol for three months, and 36.7% of the patients on similar treatment for six months. In comparison with age matched groups of patients on a regimen where streptomycin replaced ethambutol a statistically significant number of the patients on ethambutol had abnormal scores. This study suggests that Arden contrast sensitivity plates would be effective in detecting subclinical toxic optic neuropathy due to ethambutol and therefore could be used for routine monitoring of ocular function of patients on ethambutol. Loss of contrast sensitivity may explain why some patients on ethambutol with normal visual acuity and colour perception may still complain of visual disturbance.

Full text

PDF
192

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arden G. B., Jacobson J. J. A simple grating test for contrast sensitivity: preliminary results indicate value in screening for glaucoma. Invest Ophthalmol Vis Sci. 1978 Jan;17(1):23–32. [PubMed] [Google Scholar]
  2. Arden G. B. The importance of measuring contrast sensitivity in cases of visual disturbance. Br J Ophthalmol. 1978 Apr;62(4):198–209. doi: 10.1136/bjo.62.4.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arundale K. An investigation into the variation of human contrast sensitivity with age and ocular pathology. Br J Ophthalmol. 1978 Apr;62(4):213–215. doi: 10.1136/bjo.62.4.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beck R. W., Ruchman M. C., Savino P. J., Schatz N. J. Contrast sensitivity measurements in acute and resolved optic neuritis. Br J Ophthalmol. 1984 Oct;68(10):756–759. doi: 10.1136/bjo.68.10.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CARR R. E., HENKIND P. Ocular manifestations of ethambutol, Toxic amblyopia after administration of an experimental antituberculous drug. Arch Ophthalmol. 1962 May;67:566–571. doi: 10.1001/archopht.1962.00960020566009. [DOI] [PubMed] [Google Scholar]
  6. Campbell I. A., Elmes P. C. Letter: Ethambutol and the eye; zinc and copper. Lancet. 1975 Oct 11;2(7937):711–711. doi: 10.1016/s0140-6736(75)90812-0. [DOI] [PubMed] [Google Scholar]
  7. Citron K. M. Ethambutol: a review with special reference to ocular toxicity. Tubercle. 1969 Mar;50(Suppl):32–36. doi: 10.1016/0041-3879(69)90079-8. [DOI] [PubMed] [Google Scholar]
  8. Donomae I., Yamamoto K. Clinical evaluation of ethambutol in pulmonary tuberculosis. Ann N Y Acad Sci. 1966 Apr 20;135(2):849–881. doi: 10.1111/j.1749-6632.1966.tb45528.x. [DOI] [PubMed] [Google Scholar]
  9. Karmon G., Savir H., Zevin D., Levi J. Bilateral optic neuropathy due to combined ethambutol and isoniazid treatment. Ann Ophthalmol. 1979 Jul;11(7):1013–1017. [PubMed] [Google Scholar]
  10. Leibold J. E. The ocular toxicity of ethambutol and its relation to dose. Ann N Y Acad Sci. 1966 Apr 20;135(2):904–909. doi: 10.1111/j.1749-6632.1966.tb45532.x. [DOI] [PubMed] [Google Scholar]
  11. Pyle M. M. Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation. Ann N Y Acad Sci. 1966 Apr 20;135(2):835–845. doi: 10.1111/j.1749-6632.1966.tb45526.x. [DOI] [PubMed] [Google Scholar]
  12. Roberts S. M. A review of the papers on the ocular toxicity of ethambutol hydrochloride (myambutol), an anti-tuberculosis drug. Am J Optom Physiol Opt. 1974 Dec;51(12):987–992. doi: 10.1097/00006324-197412000-00008. [DOI] [PubMed] [Google Scholar]
  13. Saraux H., Bechetoille A., Nou B. Névrites optiques par éthambutol. Nouv Presse Med. 1973 Nov 10;2(40):2692–2692. [PubMed] [Google Scholar]
  14. Schmidt I. G. Central nervous system effects of ethambutol in monkeys. Ann N Y Acad Sci. 1966 Apr 20;135(2):759–774. doi: 10.1111/j.1749-6632.1966.tb45521.x. [DOI] [PubMed] [Google Scholar]
  15. Skalka H. W. Effect of age on Arden grating acuity. Br J Ophthalmol. 1980 Jan;64(1):21–23. doi: 10.1136/bjo.64.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Yiannikas C., Walsh J. C., McLeod J. G. Visual evoked potentials in the detection of subclinical optic toxic effects secondary to ethambutol. Arch Neurol. 1983 Oct;40(10):645–648. doi: 10.1001/archneur.1983.04050090081014. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES